Purchase Order 75N93023P00654

Award Date 7/30/23
Potential Completion Date 7/29/24
Potential Value $13K
Ultimate Awardee
Revvity Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Shelton, CT 06484, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a $11,007.96 firm fixed-price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide an annual Gold Service Plan with one preventative maintenance for an Envision Xcite medical device. The contract carries a one-year period of performance from February 1, 2024 through January 31, 2025. Place of performance will be in Hopkinton,...
Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded an $11,340 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to deliver one S/N IS1831N7468 IVIS Lumina LT instrument, Series III, 120V, along with a Bronze Service Plan and model INVCLS136331. The contract has a period of performance from June 25, 2023 through June 24, 2024. Place of performance will be in Shelton,...
Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a $13,560 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide a non-NIH networked computer to operate laboratory instruments. The computer will support research at the agency's facilities in Shelton, Connecticut under a one-year period of performance through July 2024. No subcontractors or set aside designations...
This is a $17,738.40 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government, to Revvity Health Sciences, Inc. The contract is for the "GOLD COVERAGE PLAN" and has an ultimate completion date of May 10, 2024. There is no set-aside designation indicated. Revvity Health Sciences, Inc. is a for-profit organization and manufacturer that provides medical imaging products and services to federal...
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a firm-fixed-price purchase order contract to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc., for preventive maintenance of the IVIS-TWINBROOK 3 facility in Bethesda, Maryland. The $19,467.03 contract has an ultimate completion date of November 30, 2012 and does not utilize a set-aside designation. Revvity Health Sciences, Inc. is a for-profit medical imaging...
Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a $14,940.06 firm fixed-price purchase order by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to deliver a CELLOMETER AUTO 2000 BUNDLE (AMBIS #2185560). Performance will occur in Shelton, Connecticut over a six-month period concluding in March 2024. No subcontractors or set-aside designations were indicated. This...
This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc. for $5,308.00 in onsite support services. The contract has a period of performance through August 1, 2015. No set-aside was used for this award. Revvity Health Sciences, Inc. is a for-profit medical imaging company that provides laboratory equipment, maintenance services, and...
The Department of Health and Human Services' National Institutes of Health awarded a firm fixed-price purchase order worth $176,376.98 to Revvity Health Sciences, Inc. for a Cellaca MX High Throughput-High Speed Cell Counting System and accessories. The contract is to support the National Institute of Allergy and Infectious Diseases (NIAID) and has a period of performance ending on July 30, 2023. There was no set-aside used for this acquisition, which was competed under Simplified Acquisition...
This contract award is for a RENEWAL MAINTENANCE AGREEMENT FOR S/N 424576 from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency. The $2,414.70 fixed-price contract was awarded to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc., on September 18, 2012 with a completion date of July 24, 2017. The contract does not have a set-aside designation. Revvity Health Sciences provides medical imaging products and services to federal agencies...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $11,793.60 firm fixed price purchase order to Revvity Health Sciences, Inc. for BRONZE SERVICE PLAN, IVIS LUMINA LT SERIES III. The contract has a completion date of June 24, 2025 and was awarded on June 25, 2024. Revvity Health Sciences, Inc. is a for-profit manufacturer of medical imaging products and services that has provided a variety of equipment and...

Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a firm fixed-price purchase order valued at thirteen thousand three hundred thirty-five dollars by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The contract is for a gold service plan with one preventative maintenance for a Cellaca MX device with AOPI configuration bundle and serial number MX-120-0261. The period of performance is one year, from July 30, 2023 to July 29, 2024, with all work taking place in Shelton, Connecticut. No subcontractors or set-aside designations were indicated. NIAID conducts and supports research on infectious, immunologic, and allergic diseases to better understand, treat, and ultimately prevent these conditions.

Generated 12/23/23, 4:58 PM